124 related articles for article (PubMed ID: 761010)
1. Restrictions on NHS prescribing in Australia.
Smith T
Br Med J; 1979 Jan; 1(6156):99-100. PubMed ID: 761010
[No Abstract] [Full Text] [Related]
2. Restrictions on NHS prescribing in Australia.
de Souza D
Br Med J; 1979 Apr; 1(6169):1018. PubMed ID: 435928
[No Abstract] [Full Text] [Related]
3. "Tough but fair"? The active management of the New Zealand drug benefits scheme by an independent Crown agency.
Davis P
Aust Health Rev; 2004 Nov; 28(2):171-81. PubMed ID: 15527397
[TBL] [Abstract][Full Text] [Related]
4. Bringing in the big guns. U.S. attorney joins civil suits against Medco Health.
Taylor M
Mod Healthc; 2003 Jul; 33(27):17. PubMed ID: 12884725
[No Abstract] [Full Text] [Related]
5. The pharmaceutical situation in the Philippines.
Hartigan-Go K
Aust Health Rev; 2001; 24(2):25-31. PubMed ID: 11496467
[No Abstract] [Full Text] [Related]
6. Inter- and intraprovincial inequities in public coverage of cancer drug programs across Canada: a plea for the establishment of a pan-Canadian pharmacare program.
Sorin M; Franco EL; Quesnel-Vallée A
Curr Oncol; 2019 Aug; 26(4):266-269. PubMed ID: 31548806
[No Abstract] [Full Text] [Related]
7. [Family physicians resist high prescription risk].
Schmidt K
MMW Fortschr Med; 2003 May; 145(20):58. PubMed ID: 12822233
[No Abstract] [Full Text] [Related]
8. Paying for prescriptions: programs that can help.
Pa Med; 2001; 104(1):7. PubMed ID: 11197143
[No Abstract] [Full Text] [Related]
9. Pharmaceutical Benefits Scheme restrictions on anti-epileptic drug prescribing promote unsafe and outdated practice.
Gericke CA; O'Brien TJ
Med J Aust; 2019 Jul; 211(2):55-57.e1. PubMed ID: 31256431
[No Abstract] [Full Text] [Related]
10. PEI government announces catastrophic drug plan.
Birchard K
CMAJ; 2013 Jul; 185(10):E432. PubMed ID: 23754110
[No Abstract] [Full Text] [Related]
11. Australia's pharmaceutical benefits system: flawed but improving, and better than anywhere else.
Dalton A
Aust Health Rev; 2001; 24(2):7-14. PubMed ID: 11496474
[No Abstract] [Full Text] [Related]
12. Patient assistance programs: information is not our enemy.
Choudhry NK; Lee JL; Agnew-Blais J; Corcoran C; Shrank WH
Health Aff (Millwood); 2009; 28(3):843-4. PubMed ID: 19414896
[No Abstract] [Full Text] [Related]
13. Advocating for a Medicare prescription drug benefit.
Rother J
Yale J Health Policy Law Ethics; 2003; 3(2):279-90. PubMed ID: 14577144
[No Abstract] [Full Text] [Related]
14. And on the cover of the guide were two words in red--don't panic.
Harvey R
Aust Health Rev; 2001; 24(2):15-20. PubMed ID: 11496457
[No Abstract] [Full Text] [Related]
15. Voluntary patient assistance programs: additional federal oversight unwarranted.
Johnson K
Health Aff (Millwood); 2009; 28(3):835-8. PubMed ID: 19414894
[TBL] [Abstract][Full Text] [Related]
16. Some over-the-counter advice on making drug therapy work. Interview by Patrick Mullen.
Gans JA
Manag Care; 2001 Oct; 10(10):41-2, 44, 47. PubMed ID: 11764745
[No Abstract] [Full Text] [Related]
17. [Open letter to minister of health. Toad medicine].
Erdmann E
Krankenpfl J; 2003; 41(4-6):110-1. PubMed ID: 12929321
[No Abstract] [Full Text] [Related]
18. [Expert evaluation of private drug prescriptions].
Kreck C; Saller R
Gesundheitswesen; 1995 May; 57(5):258-63. PubMed ID: 7620245
[TBL] [Abstract][Full Text] [Related]
19. Catastrophic health insurance: budget and policy issues.
Helms RB
Am J Pharm Educ; 1989; 53(4):356-9. PubMed ID: 10304253
[No Abstract] [Full Text] [Related]
20. A UK national prescribing list?
Walley T
Pharmacoeconomics; 1995 Jun; 7(6):471-4. PubMed ID: 10155332
[No Abstract] [Full Text] [Related]
[Next] [New Search]
